Keywords :
Adverse maternal outcome, Congophilia, Congo red paper test, Misfolded proteins, Preeclampsia, Prevention, Spectroscopy
Citation Information :
Gupta N, Gupta G, Jahan U, Bisht S. Ultraviolet Spectroscopy vs Congo Red Card Test—A Step Forward toward Early Prediction of Preeclampsia: A Case–Control Study. J South Asian Feder Obs Gynae 2024; 16 (2):192-197.
Aim: Comparative evaluation of ultraviolet–visible (UV–Vis) spectroscopy and Congo red card-based test in the diagnosis of preeclampsia.
Materials and methods: In this case–control study, UV–Vis spectroscopy and Congo red card test were done using mid-stream clean catch urine samples collected from 98 cases and 98 controls. The results obtained were used to calculate the specificity and sensitivity of each test.
Results: Out of 98 cases, 76 showed increased absorbance in UV–Vis spectroscopy while 69 showed Congo red positivity. Thus, the ultraviolet (UV)-absorbance method was found to be more sensitive (77.53) and specific (80.61) compared to the Congo red paper-based test (sensitivity, 70.40; specificity, 64.28) in the detection of the misfolded proteins present in the urine samples of the preeclamptic patients.
Conclusion: The UV–Vis absorption spectroscopy is a renowned yet innovative technique in the diagnosis of preeclampsia. It is more sensitive and specific to the existing Congo red paper-based test.
Clinical significance: Several studies show that urine of preeclampsia patients shows the presence of misfolded proteins which are present about 2 weeks before the onset of symptoms, that is, clinical diagnosis. This creates scope for early detection and diagnosis of preeclampsia. In this study, we establish the role of spectroscopy as a novel test in diagnosing misfolded proteins in preeclamptic patients and compare its diagnostic performance to the highly acclaimed Congo red card test.
World Health Organization. The World Health Report 2005. Make every mother and child count. Available at: https://www.who.int/publications/i/item/9241562900. Accessed on: 30 January 2020.
Duhig K, Vandermolen B, Shennan A. Recent advances in the diagnosis and management of pre-eclampsia. F1000Res 2018;7:242. DOI: 10.12688/f1000research.12249.1.
Wiktor H, Kankofer M, Schmerold I, et al. Oxidative DNA damage in placentas from normal and pre-eclamptic pregnancies. Virchows Archiv 2004;445(1):74–78. DOI: 10.1007/s00428-004-1024-2.
Serdar Z, Gür E, Colakoethullarý M, et al. Lipid and protein oxidation and antioxidant function in women with mild and severe preeclampsia. Arch Gynecol Obstet 2003;268(1):19–25. DOI: 10.1007/s00404-002-0302-y.
Buhimschi IA, Zhao G, Funai EF, et al. Proteomic profiling of urine identifies specific fragments of SERPINA1 and albumin as biomarkers of preeclampsia. Am J Obstet Gynecol 2008;199(5):551.e1–e16. DOI: 10.1016/j.ajog.2008.07.006.
Díaz–Villanueva J, Díaz–Molina R, García–González V. Protein Folding and Mechanisms of Proteostasis. Int J Mol Sci 2015;16(8):17193–17230. DOI: 10.3390/ijms160817193.
Buhimschi IA, Nayeri UA, Zhao G, et al. Protein misfolding, congophilia, oligomerization, and defective amyloid processing in preeclampsia. Sci Transl Med 2014;6(245):245ra92. DOI: 10.1126/scitranslmed.3008808.
Li X-M, Liu X-M, Xu J, et al. Late pregnancy screening for preeclampsia with a urinary point-of-care test for misfolded proteins. Spradley FT, editor. PLoS One 2020;15(5):e0233214. DOI: 10.1371/journal.pone.0233214.
Rood KM, Buhimschi CS, Dible T, et al. Congo red dot paper test for antenatal triage and rapid identification of preeclampsia. EClinicalMedicine 2019;8:47–56. DOI: 10.1016/j.eclinm.2019.02.004.
Nagarajappa C, Rangappa SS, Suryanarayana R, et al. Urinary congophilia in preeclampsia: Experience from a rural tertiary-care hospital in India. Pregnancy Hypertens 2018;13:83–86. DOI: 10.1016/j.preghy.2018.05.006.
Rani A, Jain M, Dash D, et al. A study on the role of urinary congophilia in early detection of preeclampsia. Ann Natl Acad Med Sci 2022;58(02):087–091. DOI: 10.1055/s-0042-1743134.